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Hyperglycemia on the oral GCT is associated with macrosomia, cesarean delivery, preeclampsia, and an increased risk of long-term complications in the offspring including childhood obesity, insulin resistance, and type 2 diabetes later in life. [1] [2] [3] [4] However, there have been limited studies regarding the implications of low 50 g GCT values, and there is no consensus on the association between an isolated low GCT value and adverse pregnancy outcomes. Some investigators have reported that maternal low GCT values are linked to an increased risk of intrauterine growth restriction and neonatal intensive care unit (NICU) admissions, 5, 6 whereas other investigators have found no relationship between low GCT values and perinatal morbidity. 7 The oral 50 g GCT has been used extensively in nearly all pregnant women, and a better understanding of the association between adverse pregnancy outcomes and low GCT values would be helpful in reducing maternal and neonatal morbidity.
The purpose of this study was to compare the pregnancy outcomes in pregnant women with low 50 g glucose challenge test (GCT) values to those of pregnant women with normal values.
II. MATERIALS AND METHODS

Study population
This retrospective study was conducted at Severance Hospital, a tertiary mg/dL following the 50 g oral glucose load were not included in the study to limit false negatives for GDM.
Definitions
Neonate birthweight percentiles were calculated according to Korean reference standards. 8 SGA was defined as a neonatal birthweight below the tenth percentile for that gestational age and large for gestational age (LGA) was defined as a neonatal birthweight above the 90th percentile for that gestational age. Low birthweight was defined as birthweight < 2500 g and macrosomia was defined as a birthweight > 4000 g. Obesity was defined as a pre-pregnancy body mass index (BMI) ≥ 25 kg/m2. Preterm delivery was defined as delivery occurring prior to 37 weeks of gestational age and early preterm delivery was defined as delivery occurring prior to 34 weeks of gestational age. Preeclampsia was diagnosed if the patient presented with a persistent blood pressure elevation above 140/90 mmHg with additional systemic features after 20 weeks of gestation. 9 PPROM was confirmed by history and visualization of vaginal pooling of amniotic fluid before the onset of labor prior to 37 weeks of gestation. Oligohydramnios was defined as a four-quadrant amniotic fluid index (AFI) of ≤ 5 cm, and polyhydramnios was defined as an AFI ≥ 25 cm. PPH was defined as the loss of more than 1000 mL of blood within the first 24 hours following childbirth. Placenta previa was defined as abnormal placentation near or covering the internal cervical os, and placenta accreta was diagnosed if the placenta attached abnormally to the myometrium, and additional interventions such as uterine artery embolization or cesarean hysterectomy were needed.
Placental abruption was defined as the premature separation of the placenta from the uterus.
Statistical analysis
For a comparison of categorical variables, Pearson's chi-square test or
Fisher's exact test were used. Continuous variables were analyzed using Student's t-test. To evaluate the crude association between low GCT levels and adverse pregnancy outcomes, logistic regression analysis was used to calculate the unadjusted odds ratios (OR) and 95% confidence intervals (95% CI). We also calculated the adjusted ORs after adjusting for potential confounding factors, including maternal age, parity, gestational age at delivery, pre-pregnancy BMI, weight gain during pregnancy, and others. A p value < 0.05 was considered statistically significant. All analyses were performed using SPSS version 23.0 (SPSS Inc. Chicago, IL, USA).
III. RESULTS
Initially, the medical records of 6257 women were reviewed for this study. Figure 1 shows the GCT values of the present study population. Of these, 579 (9.2%) had a low glucose value at one hour following a 50 g oral glucose load
(≤ 85 mg/dL). A total of 3875 women were ultimately enrolled into this study.
Among these women, 519 (13.4%) had a low GCT value and 3356 (86.6%) had a normal GCT value (86-130 mg/dL). Compared to women with a normal GCT value, women with a low GCT value were younger (p < 0.01) and had greater gestational age at delivery (p < 0.01). The proportions of women with a maternal age > 35 years and with maternal obesity (pre-pregnancy ≥ 25 kg/m2) were lower in the low GCT group than in the normal group. Other characteristics between the two groups were similar (Table 1 ).
The cesarean section rate was lower in the low GCT group than that seen in the normal GCT group (p < 0.01) as was the emergency cesarean section rate (p = 0.01). PPH also occurred less frequently in women with a low GCT value than in women with a normal GCT value (p = 0.03). There were no significant differences in other adverse pregnancy outcomes including preeclampsia, oligohydramnios, polyhydramnios, PPROM, preterm labor, preterm delivery, placenta previa, placenta accreta, and placental abruption between the two groups ( Table 2) . Neonatal outcomes are shown in Table 3 . There was a significant difference in the rate of SGA neonates between the two groups (10.8% vs. 7.9%, p = 0.02). The number of neonates with low birthweight (LBW), macrosomia, low
Apgar score (5-minute Apgar score < 7), admission to the NICU, and intrauterine fetal death were not significantly different between the two groups (Table 3) . Multivariable logistic regression analysis was used to access the associations between a low GCT value and certain adverse pregnancy outcomes while controlling for potential confounders (Table 4) . Neonates born to mothers with a low GCT value had a significantly higher risk of SGA (OR = 1.38, 95% CI 1.01-1.88) and a significantly lower risk of cesarean delivery (OR = 0.75, 95%
CI 0.61-0.92). In addition, a low GCT level was independently associated with a decreased risk for PPH (OR = 0.17, 95% CI 0.02-0.91). Early preterm delivery 0.32 (3) 0.09-1.14 0.08 PPROM 0.77 (2) 0.31-1.91 0.58
Placental abruption 0.57 (2) 0.07-4.48 0.60 PPH 0.17 (2) 0.02-0.91 0.03
1.01-1.88 0.04
Five minute APGAR <7 0.93 (2) 0.47-1.85 0.85 NICU admission 1.34 (2) 0.28-6.28 0.70
0.95-34.31 0.05
GCT, glucose challenge test; OR, odds ratio; CI, confidence interval; C-section, cesarean section; PPROM, preterm premature rupture of membrane; PPH, postpartum hemorrhage; SGA, small for gestational age; NICU, neonatal intensive care unit; IUFD, intrauterine fetal death. (1) Adjusted for age, parity, gestational age, birthweight, fetal sex, pre-pregnancy body mass index (BMI), and weight gain during pregnancy; (2) Adjusted for age, parity, gestational age, birthweight, fetal sex, pre-pregnancy BMI, and weight gain during pregnancy; (3) Adjusted for age, parity, birthweight, fetal sex, pre-pregnancy BMI, weight gain during pregnancy, preeclampsia, preterm premature rupture of membranes, and preterm labor; (4) Adjusted for age, parity, gestational age, fetal sex, pre-pregnancy BMI, and weight gain during pregnancy.
IV. DISCUSSION
The GCT is a screening tool for GDM that has been proven to be effective in nearly the entire population of pregnant women, and nearly all pregnant women undergo a 50 g GCT between 24 and 28 weeks of gestation, except those with a high risk of diabetes. Hyperglycemia is associated with morbidity during pregnancy, and recently it has been reported that obstetrical complications increase proportionally with the continuum of maternal hyperglycemia. 10 However, the significance of a low maternal GCT value remains uncertain. In this study, we found that a low GCT value has significant clinical implications.
A low GCT value was significantly associated with an increased risk of SGA neonates compared to that of the normal GCT group. Consistent with our study, several previous studies have shown an association between a low GCT value and SGA neonates or low birthweight. One study reported that women with a low GCT value have a 2.65 times greater risk of having an SGA baby than women with a normal GCT value (p = 0.002). 11 Melamed et al. reported that a low GCT value was independently associated with an increased risk for low birthweight (< 2500 g) and birthweights < the tenth, fifth, and third percentiles. 5 Other studies have shown a relationship between maternal low GCT values and SGA infants. 12, 13 Topçu et al. reported that neonatal birth weight was correlated with GCT results, and that this relationship was more prominent in male infants.
14 Maternal glucose metabolism changes dramatically during pregnancy since glucose is the principal fetal nutrient. Glucose is provided to the fetus through the placental circulation and the maternal-fetal glucose gradient. Insulin is a key growth factor for fetal development, and the fetus produces its own insulin in response to glucose stimulation. Fetal growth restriction may be directly linked to a deficiency of glucose as a nutrient source and may be indirectly related with excess insulin sensitivity. Rogne and Jacobsen reported that an insufficient increase in maternal glucose levels after a glucose challenge was associated with an increased risk for impaired fetal growth. 15 Furthermore, several studies have reported an increased insulin sensitivity in pregnancies with intrauterine growth restriction. [16] [17] [18] In an animal study, maternal low glucose values during pregnancy were associated with a decrease in fetal glucose, which lead to diminished fetal growth rates and decreased fetal insulin. 19 Although there are controversies regarding the association between low maternal glucose levels and fetal growth restriction, many studies have reported a high proportion of SGA neonates in women with low GCT values.
We found that the low GCT value group had lower cesarean section and emergency cesarean section rates compared to that seen in the normal group.
These findings are consistent with those of other studies. 5, 14 This phenomenon may be related to the lower maternal obesity rates in the low GCT level group.
In our study, the most common indications for emergency cesarean delivery were cephalopelvic disproportion (292/588, 49.6%) and failure to progress (96/588, 16.3%). Compared to women with normal GCT values, those with low GCT values were less likely to be obese (pre-pregnancy BMI ≥ 25 ) (p < 0.01). Maternal obesity is associated with a risk of cesarean section because of pelvic narrowing from adipose tissue and inefficient uterine contractions due to the release of inflammatory mediators from adipose tissue. 20, 21 Similarly, other studies have reported that the incidence of cesarean section and pre-pregnancy BMI is lower in women with low GCT values in comparison to women with normal GCT values. 5, 14 We also demonstrated that the low GCT group had a lower rate of PPH than did the normal GCT group. The reason for this relationship is not clear and this observation has not been previously reported to the best of our knowledge. One can speculate that lower rates of maternal obesity and LGA in women with low GCT levels is associated with a decreased risk of PPH, since maternal obesity and LGA are risk factors of PPH, and these two factors are less common in women with low GCT levels.
We did not detect any significant association between low GCT values and other complications such as preterm delivery, low Apgar score, and the rate of admission to the NICU. It is tempting to speculate that a prolonged decrease in maternal glucose levels might lead to decreased fetal glucose levels, increased protein breakdown, and increased oxidative metabolism, adversely affecting the intrauterine environment. Although the mechanisms are not clear and there are many confounding factors, one possible explanation is that a low glucose value with a 50 g glucose load does not accurately reflect maternal glucose levels. However, because hyperglycemia in 50g GCT reflects abnormal maternal insulin resistance, low glucose values with a 50g glucose load may reflect increased maternal insulin sensitivity. Further research regarding a relative increase in maternal insulin sensitivity and other factors affecting maternal glucose metabolism are needed to more clearly define the relationship between a low GCT value and adverse perinatal outcomes such as preterm delivery and perinatal morbidities.
A strength of our study is the large homogeneous sample. In addition, we evaluated various maternal and neonatal outcomes in order to define the relationships between low GCT values and maternal and neonatal complications. Our study is limited by its retrospective design. The study design was limited to an evaluation of long-term complications associated with a low GCT level. Additionally, our study has a potential selection bias because the study was conducted in a tertiary referral center that has high proportion of high-risk pregnancies. Some pre-referral data were also incomplete.
V. CONCLUSION
We found that maternal low glucose levels following a 1-hour oral GCT are associated with a higher incidence of SGA infants and a lower incidence of cesarean section and PPH. A low GCT was independently associated with an increased risk for SGA infants. We suggest that a low 50 g GCT glucose value may be useful for predicting the birth of an SGA infant. Careful attention should be paid to women with low GCT values. 
